https://www.viecure.com/orion-newsletter/the-power-of-conversational-presence-and-provider-engagement 2024-07-25 https://www.viecure.com/orion-newsletter/precision-oncology%3A-where-are-we-headed%3F 2024-05-20 https://www.viecure.com/orion-newsletter/the-impact-of-jemperli-and-its-applications-in-cancer-care 2024-03-12 https://www.viecure.com/orion-newsletter/barriers-to-medication-adherence-in-community-oncology-practices 2024-03-12 https://www.viecure.com/orion-newsletter/clinical-opportunities-within-cancer-management-for-histology-agnostic-drugs 2024-02-01 https://www.viecure.com/orion-newsletter/the-significance-of-early-palliative-discussions-in-community-oncology-practices 2024-03-12 https://www.viecure.com/orion-newsletter/the-benefits-of-embedding-clarifiedselect-reports-within-the-viecure-clinical-workflow 2023-08-18 https://www.viecure.com/orion-newsletter/cancers%3A-looking-beyond-genes 2023-05-16 https://www.viecure.com/orion-newsletter/longitudinal-(ctc)-determination%3A-in-search-of-a-impending-opportunity 2023-06-06 https://www.viecure.com/orion-newsletter/welcome-to-pandemicine-...-an-opinion-piece- 2023-08-18 https://www.viecure.com/orion-newsletter/providing-opportunities-for-continuing-medical-education-within-a-rapidly-progressing-oncology-clinical-setting- 2024-03-12 https://www.viecure.com/orion-newsletter/improving-remote-patient-monitoring-in-the-community-oncology-setting 2023-08-18 https://www.viecure.com/orion-newsletter/clinical-trials-participation-in-community-oncology%3A--challenges-%26-opportunities-part-2 2023-08-18 https://www.viecure.com/orion-newsletter/real-world-data%3A-powering-innovations-in-cancer-care 2023-08-18 https://www.viecure.com/orion-newsletter/rare-cancer%3A-unmet-needs-%26-implications-for-community-practice 2023-08-18 https://www.viecure.com/orion-newsletter/opportunities-for-proteomics-in-the-community-oncology-setting 2023-08-18 https://www.viecure.com/orion-newsletter/covid-19-and-cancer%3A-recap-of-the-recommendations 2023-08-18 https://www.viecure.com/orion-newsletter/compassion%3A-key-in-supportive-care 2023-08-18 https://www.viecure.com/orion-newsletter/supporting-survivorship-care-in-the-community-oncology-setting%3A-key-issues-and-opportunities 2023-08-18 https://www.viecure.com/orion-newsletter/inequalities%2C-social-determinants-of-health-and-poor-outcomes%3A-implications-for-community-oncology-practice. 2023-08-18 https://www.viecure.com/orion-newsletter/evolution-of-molecular-testing%3A-implications-for-community-oncology-practice 2023-08-18 https://www.viecure.com/orion-newsletter/cardiotoxicities-%26-genomic-guided-treatments%3A-issues-for-treatment-decision-making%2C-monitoring%2C-%26-management 2023-08-18 https://www.viecure.com/orion-newsletter/radiopharmaceuticals%3A-driving-a-paradigm-shift-in-cancer-treatment 2023-08-18 https://www.viecure.com/orion-newsletter/ageism-in-cancer-care- 2023-08-18 https://www.viecure.com/orion-newsletter/clinical-trial-participation-in-community-oncology%3A-challenges-and-opportunities- 2023-08-18 https://www.viecure.com/orion-newsletter/testing-for-both-germline-and-somatic-mutations-in-prostate-and-other-cancers%3A-impact-on-treatment-decision-making- 2023-08-18 https://www.viecure.com/orion-newsletter/covid-19-and-patient-volumes-in-the-community-oncology-practice-setting- 2022-06-04 https://www.viecure.com/orion-newsletter/clinical-advisory-council-highlight%3A-skin-toxicities-associated-with-novel-immunotherapies 2023-08-18 https://www.viecure.com/orion-newsletter/real-world-data-and-the-potential-to-identify-oncology-therapeutic-options 2022-06-04 https://www.viecure.com/orion-newsletter/treatment-of-lung-cancer%3A-a-paradigm-shift 2023-08-18 https://www.viecure.com/orion-newsletter/germline-testing-in-oncology 2023-08-18 https://www.viecure.com/orion-newsletter/lung-cancer-awareness-month%3A-highlighting-the-importance-of-screening 2023-08-18 https://www.viecure.com/orion-newsletter/accelerating-personalized-medicine-adoption-in-community-oncology%3A-solving-the-transformation-to-compete-successfully-in-the-2020's-and-beyond 2023-08-18 https://www.viecure.com/orion-newsletter/precision-medicine%3A-the-need-for-expanded-compassionate-use-programs 2023-08-18 https://www.viecure.com/orion-newsletter/perspectives-and-recommendations-on-cancer-survivorship-care-during-covid-19-from-the-mascc-survivorship-group 2023-08-18 https://www.viecure.com/orion-newsletter/precision-medicine%3A-accelerating-cancer's-demise 2023-08-18 https://www.viecure.com/orion-newsletter/pharmacogenomics-%26-personalized-medicine-management%3A-opportunities-%26-challenges 2023-08-18 https://www.viecure.com/orion-newsletter/impacts-of-covid-19-on-cancer-supportive-care%3A-interviews-with-drs.-annie-young-and-ian-olver 2023-08-18 https://www.viecure.com/orion-newsletter/experience-of-next-generation-sequencing-in-the-medicare-eligible-cancer-patient-population%3A-community-oncology-practice-in-response-to-cms-next-generation-sequencing-policy 2023-08-18 https://www.viecure.com/orion-newsletter/community-oncology-practice-adoption-of-genomic-guided-medicine%3A-key-issues 2023-08-18